Dr.Exsol is a pioneering research and development company in the healthcare industry with the slogan "Crafting Science-Driven Health Solutions for a Brighter Future." Specializing in the creation of evidence-based healthcare content, they prioritize clinical and preclinical R&D. Founded in 2021, the company's mission is to develop personalized health solutions grounded firmly in scientific evidence. Dr.Exsol has a keen focus on preventing four major diseases: sarcopenia, cancer survivorship issues, prediabetes, and mild cognitive impairment. The company's strength is anchored in the robust research capabilities of its management team. Their last investment was a Seed Round investment at 11 March 2022, and it was made by Commax Venturus.
No recent news or press coverage available for Dr.Exsol.